share_log

AEON Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Thunen Shelley B

SEC ·  Sep 5, 2024 09:55
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more